For example, the breast cancer 21-gene assay (Oncotype DX) is used to predict the recurrence risk and chemotherapy benefits in patients with hormone receptor-positive, HER2 receptor negative and lymph node-negative subtypes (59). The gene discussed is NR4A1; the disease is breast cancer.